drugset

drugset / Trial / NCT03616392

Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

NCT03616392 ↗

Phase 1 Completed 41 enrolled Chong Kun Dang Pharmaceutical

RandomizedCrossoverOpen-labelTreatment

Summary

Phase 1 trial to evaluate the drug drug interaction of CKD-501 and D308

Timeline

Start: 2018-07-25
Primary completion: 2018-09-17
Completion: 2018-11-13

Publications

Jang K, Jeon JY, Moon SJ, Kim MG. Evaluation of the Pharmacokinetic Interaction Between Lobeglitazone and Dapagliflozin at Steady State. Clin Ther. 2020 Feb;42(2):295-304. doi: 10.1016/j.clinthera.2020.01.003. Epub 2020 Jan 25.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dapagliflozin	Small molecule	—	Oral
Subject	Lobeglitazone	Small molecule	0.5 mg	Oral

Indications